<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04737941</url>
  </required_header>
  <id_info>
    <org_study_id>3/2021</org_study_id>
    <nct_id>NCT04737941</nct_id>
  </id_info>
  <brief_title>Finnish Venous Ulcer Study (FINNULCER Study)</brief_title>
  <official_title>Finnish Venous Ulcer Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oulu University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicenter randomized controlled trial compares immediate foam sclerotherapy vs.&#xD;
      scheduled endovenous treatment in patients with venous ulceration.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the effect of first-visit foam sclerotherapy, patients with venous ulcer are&#xD;
      randomly assigned to first-visit foam sclerotherapy- or to scheduled treatment group. The&#xD;
      primary outcome for this study is time to ulcer healing.&#xD;
&#xD;
      For this study, based on Oulu University Hospital's retrospective data (partly published in&#xD;
      Pihlaja et al 2020) of venous ulcer healing the investigators assumed Hazard Ratio 1.5 for&#xD;
      venous ulcer to heal in first-visit foam sclerotherapy group compared to scheduled treatment&#xD;
      group.&#xD;
&#xD;
      Assuming drop-out of 10% this study recruits total of 248 patients (a=0.05, b=0.2).&#xD;
&#xD;
      For the primary outcome the follow-up time is one year. In both groups endothermal ablation&#xD;
      and/or foam sclerotherapy are used to treat the ulcer-related insufficient veins and truncal&#xD;
      insufficiency. Class 2 thigh-high compression, or best possible compression therapy patient&#xD;
      tolerates is facilitated in both groups&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 26, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to ulcer Healing</measure>
    <time_frame>0-365 days</time_frame>
    <description>Complete re-epithelialisation of ulcer area</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EQ-5D Questionnaire</measure>
    <time_frame>0-365 days</time_frame>
    <description>Score 0-100 where higher is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound-QOL Questionnaire</measure>
    <time_frame>0-365 days</time_frame>
    <description>Score 0-17 where lower is better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Venous ulcer area</measure>
    <time_frame>0-365 days</time_frame>
    <description>Reduction on venous ulcer maximum diameter</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">248</enrollment>
  <condition>Venous Ulcer</condition>
  <arm_group>
    <arm_group_label>Immediate foam sclerotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Immediate foam sclerotherapy group patients are treated with immediate (first-visit) foam sclerotherapy and truncal vein endothermal ablation is scheduled when anatomy is suitable. Compression therapy is started immediately.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Scheduled treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Scheduled treatment group patients are treated with scheduled endovenous ablation including foam sclerotherapy and/or endothermal ablation depending on reflux anatomy. Compression therapy is started immediately.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endothermal Ablation</intervention_name>
    <description>Endothermal ablation is performed to suitable insufficient truncal veins (Great-, Anterior Accessory- and/or Small Saphenous Vein)</description>
    <arm_group_label>Immediate foam sclerotherapy</arm_group_label>
    <arm_group_label>Scheduled treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Foam Sclerotherapy</intervention_name>
    <description>Foam sclerotherapy is performed to insufficient veins distal to the truncal superficial veins.</description>
    <arm_group_label>Immediate foam sclerotherapy</arm_group_label>
    <arm_group_label>Scheduled treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient informed consent&#xD;
&#xD;
          -  Venous ulcer, aged from one month to one year&#xD;
&#xD;
          -  Duplex ultrasonography verified (vein reflux greater than &gt;0.5 second) superficial&#xD;
             venous insufficiency&#xD;
&#xD;
          -  Sufficient arterial circulation (at least on criterion met: Palpable distal pulses /&#xD;
             ankle-brachial index &gt; 0,8 / Toe pressure &gt;60mmhg)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Leg ulcers other than venous etiology&#xD;
&#xD;
          -  Ulcers requiring operation theater revision&#xD;
&#xD;
          -  Patent foramen ovale&#xD;
&#xD;
          -  Several times recurrent (over 3 recurrences) venous ulcer&#xD;
&#xD;
          -  Body Mass Index over 40&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toni Pihlaja, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karoliina Halmesmaki, Docent</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maarit Venermo, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matti Pokela, Docent</last_name>
    <role>Study Chair</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matti Pokela, Docent</last_name>
    <phone>083152011</phone>
    <phone_ext>+315</phone_ext>
    <email>matti.pokela@ppshp.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karoliina Halmesmaki, Docent</last_name>
      <email>karoliina.halmesmaki@hus.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tommi Auvinen, MD</last_name>
      <email>tommi.auvinen@kuh.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Paijat-Hame Central Hospital</name>
      <address>
        <city>Lahti</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sari Vähäaho</last_name>
      <email>sari.vahaaho@phhyky.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matti Pokela, Docent</last_name>
      <email>matti.pokela@ppshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Satakunta Central Hospital</name>
      <address>
        <city>Pori</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harri Hakovirta, Professor</last_name>
      <email>harri.hakovirta@tyks.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jukka Saarinen, Docent</last_name>
      <email>jukka.saarinen@pshp.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harri Hakovirta, Professor</last_name>
      <email>harri.hakovirta@tyks.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vaasa Central Hospital</name>
      <address>
        <city>Vaasa</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vesa Rajala, MD</last_name>
      <email>vesa.rajala@vshp.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Pihlaja T, Torro P, Ohtonen P, Romsi P, Pokela M. Ten years of experience with first-visit foam sclerotherapy to initiate venous ulcer healing. J Vasc Surg Venous Lymphat Disord. 2021 Jul;9(4):954-960. doi: 10.1016/j.jvsv.2020.11.012. Epub 2020 Nov 25.</citation>
    <PMID>33248300</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 30, 2021</study_first_submitted>
  <study_first_submitted_qc>January 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 4, 2021</study_first_posted>
  <last_update_submitted>March 3, 2021</last_update_submitted>
  <last_update_submitted_qc>March 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oulu University Hospital</investigator_affiliation>
    <investigator_full_name>Toni Pihlaja</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Venous ulcer</keyword>
  <keyword>Foam sclerotherapy</keyword>
  <keyword>Endothermal ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

